title: Towards non-invasive monitoring of pathogen-host interactions during Candida albicans biofilm formation using in vivo bioluminescence.
abstract: Candida albicans is a major human fungal pathogen causing mucosal and deep tissue infections of which the majority is associated with biofilm formation on medical implants. Biofilms have a huge impact on public health, as fungal biofilms are highly resistant against most antimycotics. Animal models of biofilm formation are indispensable for improving our understanding of biofilm development inside the host, their antifungal resistance and their interaction with the host immune defence system. In currently used models, evaluation of biofilm development or the efficacy of antifungal treatment is limited to ex vivo analyses, requiring host sacrifice, which excludes longitudinal monitoring of dynamic processes during biofilm formation in the live host. In this study, we have demonstrated for the first time that non-invasive, dynamic imaging and quantification of in vitro and in vivo C. albicans biofilm formation including morphogenesis from the yeast to hyphae state is feasible by using growth-phase dependent bioluminescent C. albicans strains in a subcutaneous catheter model in rodents. We have shown the defect in biofilm formation of a bioluminescent bcr1 mutant strain. This approach has immediate applications for the screening and validation ofantimycotics under in vivo conditions, for studying host-biofilm interactions in different transgenic mouse models and for testing the virulence of luminescent C. albicans mutants, hereby contributing to a better understanding of the pathogenesis of biofilm-associated yeast infections.
authors: Biomedical MRI/MoSAIC, Department Imaging & Pathology, KU Leuven, Leuven, Flanders, Belgium.
authors: Greetje
authors: G
authors: Vande Velde
authors: Soňa
authors: S
authors: Kucharíková
authors: Sanne
authors: S
authors: Schrevens
authors: Uwe
authors: U
authors: Himmelreich
authors: Patrick
authors: P
authors: Van Dijck
mesh_terms: D000818:Animals; D000935:Antifungal Agents / Q000008:administration & dosage / Q000302:isolation & purification; D018441:Biofilms / Q000254:growth & development*; D002176:Candida albicans / Q000254:growth & development / Q000502:physiology*; D002177:Candidiasis / Q000382:microbiology / Q000473:pathology; D055499:Catheter-Related Infections / Q000382:microbiology / Q000473:pathology; D003584:Cytological Techniques / Q000379:methods*; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical / Q000379:methods; D054884:Host-Pathogen Interactions; D008163:Luminescent Measurements / Q000379:methods*; D051379:Mice; D008807:Mice, Inbred BALB C; D008822:Mice, Transgenic; D008828:Microbiological Techniques / Q000379:methods*; D017207:Rats, Sprague-Dawley
chemical_list: D000935:Antifungal Agents
references: Lancet Infect Dis. 2003 Nov;3(11):685-702
references: 14592598
references: Biochem J. 1993 Dec 15;296 ( Pt 3):549-51
references: 8280050
references: Microb Pathog. 2006 Feb;40(2):82-90
references: 16426810
references: J Med Microbiol. 2011 Sep;60(Pt 9):1261-1269
references: 21566087
references: J Antimicrob Chemother. 2009 Sep;64(3):567-70
references: 19584104
references: J Antimicrob Chemother. 2002 Jun;49(6):973-80
references: 12039889
references: J Med Microbiol. 1999 Jul;48(7):671-679
references: 10403418
references: Cell Microbiol. 2007 Oct;9(10):2315-22
references: 17587328
references: Curr Biol. 2005 Jun 21;15(12):1150-5
references: 15964282
references: Curr Opin Microbiol. 2006 Dec;9(6):588-94
references: 17055772
references: Trends Microbiol. 2003 Jan;11(1):30-6
references: 12526852
references: Trends Microbiol. 2001 Jan;9(1):34-9
references: 11166241
references: Enferm Infecc Microbiol Clin. 2012 Feb;30(2):90-8
references: 22079232
references: Curr Opin Microbiol. 2006 Aug;9(4):340-5
references: 16815078
references: Antimicrob Agents Chemother. 2013 May;57(5):2365-8
references: 23403433
references: Curr Opin Pharmacol. 2010 Oct;10(5):522-30
references: 20598943
references: PLoS Pathog. 2006 Jul;2(7):e63
references: 16839200
references: J Biol Chem. 1996 Mar 15;271(11):6298-305
references: 8626424
references: Mol Ther. 2005 Mar;11(3):435-43
references: 15727940
references: Microbiol Mol Biol Rev. 2007 Jun;71(2):348-76
references: 17554048
references: Crit Rev Microbiol. 2010;36(1):1-53
references: 20088682
references: Infect Immun. 2009 Nov;77(11):4847-58
references: 19687206
references: Antimicrob Agents Chemother. 2010 Oct;54(10):4474-5
references: 20660685
references: Mol Microbiol. 1995 Nov;18(4):593-603
references: 8817482
references: Luminescence. 2012 May-Jun;27(3):234-41
references: 22362656
references: Antimicrob Agents Chemother. 1995 Sep;39(9):2128-31
references: 8540729
references: Nature. 2012 Apr 11;484(7393):186-94
references: 22498624
references: J Med Microbiol. 2006 Jul;55(Pt 7):809-818
references: 16772406
references: Antimicrob Agents Chemother. 2002 Nov;46(11):3499-505
references: 12384356
references: Clin Infect Dis. 2005 Aug 15;41(4):521-6
references: 16028162
references: PLoS One. 2007 Feb 21;2(2):e241
references: 17311106
references: Antimicrob Agents Chemother. 2004 Sep;48(9):3291-7
references: 15328087
references: Trends Biotechnol. 2011 Dec;29(12):624-33
references: 21788092
references: Virulence. 2012 Jan-Feb;3(1):51-61
references: 22286700
references: Lancet Infect Dis. 2003 Dec;3(12):772-85
references: 14652203
references: J Microbiol. 2011 Apr;49(2):171-7
references: 21538235
references: Mol Imaging. 2004 Jan;3(1):43-54
references: 15142411
references: Indian J Med Microbiol. 2012 Jul-Sep;30(3):270-8
references: 22885191
references: Microbiology (Reading). 2010 Mar;156(Pt 3):909-919
references: 19959578
references: Infect Immun. 2004 Oct;72(10):6023-31
references: 15385506
references: Antimicrob Agents Chemother. 2004 May;48(5):1727-32
references: 15105127
references: Methods Mol Biol. 2014;1098:153-67
references: 24166376
references: Clin Infect Dis. 2004 Aug 1;39(3):309-17
references: 15306996
references: Mol Gen Genet. 1984;198(2):179-82
references: 6394964
references: Curr Gene Ther. 2012 Feb 1;12(1):12-9
references: 22263920
references: BMC Mol Biol. 2006 Aug 04;7:25
references: 16889665
references: Mol Ther. 2010 Dec;18(12):2130-8
references: 20664525
references: Med Mycol. 2006 Dec;44(8):697-705
references: 17127626
references: Virulence. 2010 May-Jun;1(3):174-6
references: 21178436
references: Nat Rev Microbiol. 2011 Aug 16;9(10):737-48
references: 21844880
references: Int J Microbiol. 2012;2012:956794
references: 22121368
references: J Infect Dis. 2012 Dec 1;206(11):1790-7
references: 22984120